Cipla says supply of COVID-19 drug remdesivir catching up with demand

Backorders and complaints over low supply started moderating in the second week of May, the drugmaker said, after it began ramping up production of the antiviral drug last month.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2SS4IVL
via IFTTT